This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Anglo American | Goldman Sachs ups TP to 1,210p from 1,100p, sell |
| Babcock International | Jefferies ups TP to 1675p from 1600p, Buy |
| Barclays | RBC cuts TP to 300p from 310p, outperform |
| Barclays | UBS cuts TP to 280p from 295p, neutral |
| Barclays | JP Morgan cuts TP to 300p from 315p, overweight |
| Catlin Group | Morgan Stanley ups TP to 533p from 519p, underweight |
| Catlin Group | Espirito Santo Investment Bank ups fair value to 610p from 602p, Buy |
| Centrica | Goldman Sachs cuts TP to 381p from 423p, Buy |
| Cineworld Group | Panmure ups TP to 295p from 260p, sell |
| Coca Cola HBC AG | JP Morgan cuts TP to 1770p from 1860p, overweight |
| GlaxoSmithKline | Jefferies cuts TP to 1650p from 1750p, Hold |
| Glencore Xstrata | Goldman Sachs ups TP to 325p from 320p, Neutral |
| Hargreaves Lansdown | JP Morgan cuts TP to 1580p from 1656p, overweight |
| Kazakhmys | Barclays ups to Equalweight from underweight; TP to 220p from 192p |
| Ladbrokes | Barclays cuts TP to 123p from 169p, underweight |
| Lidco Group | Finncap ups TP to 30p |
| Shire | Citigroup removes from Europe focus list |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research